Clinical Trial

Simplified Treatment of Anti-retrovirus in China (C-STAR)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 14, 2022 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
To observe the efficacy and safety of simplified therapy regimen for treating with HIV-1 infected patients in Chinese real word.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2018-07-19; most recent amendment 2022-09-13.
Trial Details
NCT Number NCT03603977
Lead Sponsor Guangzhou 8th People's Hospital
Collaborators: Guiyang Public Health Clinical Center, The Third People's Hospital of Kunming, Nanning Second People's Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, The Third People's Hospital of Guilin, Guangxi Longtan hospital, The Fourth People's Hospital of Nanning, LiuZhou People's Hospital, Tianjin Second People's Hospital, Shenyang Sixth People's Hospital, The Sixth People's Hospital of Henan, The Sixth People's Hospital of Xinjiang, The Eighth People's Hospital of Xi'an
Conditions HIV/AIDS
Enrollment 600 participants
Start Date 2017-11-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2030-10-31 (estimated)
Updated on ClinicalTrials.gov 2022-09-14